Hoth Therapeutics旗下子公司Rocket One已成功从弗吉尼亚联邦大学获得人工智能半导体与自旋电子技术的独家权利。这项协议标志着公司在尖端科技领域的战略布局迈出关键一步，为其在快速增长的人工智能硬件市场奠定了坚实基础。
自旋电子技术作为下一代计算与存储的核心，结合人工智能半导体的前沿设计，有望显著提升数据处理效率与能效。此次独家授权不仅强化了Hoth Therapeutics的技术储备，也可能为其带来新的商业机遇与竞争优势。市场观察人士正密切关注这一进展对公司未来发展的潜在影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.